The Food and Drug Administration and Centers for Disease Control recommended on Tuesday that states temporarily halt using Johnson & Johnson's Covid-19 vaccine due to "extremely rare" blood clotting disorders that occurred in six women who received the vaccine in the U.S.

For context, more than 6.8 million doses of the J&J vaccine have been administered in the United States to date.